Total Payments
$3,570
2021 Payments
$129.21
Companies
10
Transactions
30
Payment Breakdown by Category
Consulting$2,500 (70.0%)
Travel$628.24 (17.6%)
Food & Beverage$441.85 (12.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 1 | 70.0% |
| Travel and Lodging | $628.24 | 3 | 17.6% |
| Food and Beverage | $441.85 | 26 | 12.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $3,142 | 5 | $0 (2020) |
| Allergan, Inc. | $134.61 | 8 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $128.99 | 7 | $0 (2021) |
| Lundbeck LLC | $49.45 | 3 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $32.06 | 2 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $18.46 | 1 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $18.43 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $17.25 | 1 | $0 (2020) |
| AbbVie Inc. | $15.55 | 1 | $0 (2021) |
| Noven Therapeutics, LLC | $13.04 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $129.21 | 7 | Vanda Pharmaceuticals Inc. ($81.93) |
| 2020 | $246.28 | 15 | Allergan, Inc. ($118.74) |
| 2019 | $66.36 | 4 | Otsuka America Pharmaceutical, Inc. ($32.06) |
| 2017 | $3,128 | 4 | Alkermes, Inc. ($3,128) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/24/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/02/2021 | Noven Therapeutics, LLC | SECUADO (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: SCHIZOPHRENIA | ||||||
| 01/29/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/23/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/20/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/15/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROLOGY | ||||||
| 11/24/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CNS | ||||||
| 11/18/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/06/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/11/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2020 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: PSYCHIATRY | ||||||
| 02/17/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.25 | General |
| 02/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Neuroscience | ||||||
About Dr. Michael Bohn, MD
Dr. Michael Bohn, MD is a Addiction Psychiatry healthcare provider based in Franklin, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962411686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bohn, MD has received a total of $3,570 in payments from pharmaceutical and medical device companies, with $129.21 received in 2021. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($2,500).
Ad
Practice Information
- Specialty Addiction Psychiatry
- Other Specialties Psychiatry
- Location Franklin, WI
- Active Since 08/05/2006
- Last Updated 08/26/2019
- Taxonomy Code 2084P0802X
- Entity Type Individual
- NPI Number 1962411686
Products in Payments
- Vivitrol 380 mg (Drug) $3,128
- VRAYLAR (Drug) $150.16
- HETLIOZ (Drug) $128.99
- REXULTI (Drug) $37.21
- ABILIFY MYCITE (Drug) $32.06
- INGREZZA (Drug) $18.46
- INVEGA SUSTENNA (Drug) $18.43
- ARISTADA (Drug) $14.01
- SECUADO (Drug) $13.04
- ABILIFY MAINTENA (Drug) $12.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.